Literature DB >> 19225248

Clinical spectrum, presentation, and risk factors for mortality in infective endocarditis: a review of 68 cases at a tertiary care center in Turkey.

Aylin Tuğcu1, Ozlem Yildirimtürk, Corç Baytaroğlu, Hilal Kurtoğlu, Ozkan Köse, Murat Sener, Saide Aytekin.   

Abstract

OBJECTIVES: This study was designed to evaluate clinical, laboratory, microbiological, and echocardiographic characteristics of infective endocarditis (IE) at a tertiary care center in Turkey and to identify predictors of in-hospital mortality. STUDY
DESIGN: Based on a systematic retrospective review of clinical records covering 1997 to 2007, we analyzed data and outcomes of 68 patients (40 males, 28 females; mean age 51+/-20 years) with definite or possible IE according to the modified Duke criteria.
RESULTS: Native valve endocarditis (NVE) was seen in 28 patients (41.2%), and prosthetic valve endocarditis (PVE) was seen in 38 patients (55.9%). Pacemaker endocarditis (PE) was observed in only two patients (2.9%). Nineteen patients (27.9%) had nosocomial IE. The most frequent predisposing factor for NVE was rheumatic heart disease (n=11; 39.3%). Echocardiography failed to show any signs of involvement in five patients (13.2%) with PVE. The most common causative microorganisms of NVE, PVE, and PE were staphylococci (n=28; 41.2%). At least one complication developed in 46 patients (67.7%), congestive heart failure being the most common (n=38; 55.9%). Forty-one patients (60.3%) underwent combined medical and surgical treatment. In-hospital mortality occurred in 17 patients (25%). Mortality rates were 37.5%, 30%, and 14.3% for early and late PVE and NVE, respectively. Mortality was significantly higher with nosocomial IE (57.9%) compared to 12.2% in the remaining patients. In multivariate analysis, septic shock (p=0.011) and nosocomial infection (p=0.032) were independently associated with in-hospital mortality.
CONCLUSION: Compared to the European series, IE in our cohort occurred in a relatively younger population, with rheumatic heart disease as the most common underlying heart disease. The rates of PVE, nosocomial IE, and surgical treatment were about the same.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19225248

Source DB:  PubMed          Journal:  Turk Kardiyol Dern Ars        ISSN: 1016-5169


  13 in total

1.  Risk factors of mid-term mortality of patients with infective endocarditis.

Authors:  A Nomura; F Omata; K Furukawa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-17       Impact factor: 3.267

2.  Global trends in infective endocarditis epidemiology.

Authors:  Haur Sen Yew; David R Murdoch
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

3.  Abscess, aneurysm, fistula, and complete AV block in infective endocarditis of the aortic valve: the four horsemen of the apocalypse.

Authors:  S Acikel; H Kilic; M Dogan; E Yeter
Journal:  Herz       Date:  2013-08-02       Impact factor: 1.443

Review 4.  The causative agents in infective endocarditis: a systematic review comprising 33,214 cases.

Authors:  Christiana T Vogkou; Nikolaos I Vlachogiannis; Leonidas Palaiodimos; Antonis A Kousoulis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-11       Impact factor: 3.267

5.  Endocarditis in a large district general hospital: A study of the microbiological spectrum between 2000 and 2011.

Authors:  Reza Ashrafi; Ewan McKay; Lloyd Ebden; Julia Jones; Gershan K Davis; Malcolm I Burgess
Journal:  Exp Clin Cardiol       Date:  2012

6.  Infective endocarditis: a tertiary referral centre experience from Turkey.

Authors:  Fahriye Vatansever Agca; Necmiye Demircan; Tezcan Peker; Hasan Ari; Kemal Karaagac; Ozlem Arican Ozluk; Mustafa Yilmaz; Erhan Tenekecioglu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

7.  An epidemiological study to define the recent clinical characteristics and outcomes of infective endocarditis in southern Turkey.

Authors:  Aynur Acibuca; Mustafa Yilmaz; Sefa Okar; Ebru Kursun; Onur Acilar; Abdullah Tekin; Yusuf Ziya Demiroglu; Ibrahim Haldun Muderrisoglu
Journal:  Cardiovasc J Afr       Date:  2021-04-07       Impact factor: 1.167

8.  The Lantibiotic Lacticin 3147 Prevents Systemic Spread of Staphylococcus aureus in a Murine Infection Model.

Authors:  Clare Piper; Pat G Casey; Colin Hill; Paul D Cotter; R Paul Ross
Journal:  Int J Microbiol       Date:  2012-01-12

9.  Impact of routine cerebral CT angiography on treatment decisions in infective endocarditis.

Authors:  Marwa Sayed Meshaal; Hussein Heshmat Kassem; Ahmad Samir; Ayman Zakaria; Yasser Baghdady; Hussein Hassan Rizk
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

Review 10.  Infective endocarditis epidemiology over five decades: a systematic review.

Authors:  Leandro Slipczuk; J Nicolas Codolosa; Carlos D Davila; Abel Romero-Corral; Jeong Yun; Gregg S Pressman; Vincent M Figueredo
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.